Search

Author/Creator Fenton, Keenan

1. Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study. Issue 2 (16th February 2021)

Authors:
Hutchings, Martin; Radford, John; Ansell, Stephen M.; Illés, Árpád; Sureda, Anna; Connors, Joseph M.; Sýkorová, Alice; Shibayama, Hirohiko; Abramson, Jeremy S.; Chua, Neil S.; Friedberg, Jonathan W.; Kořen, Jan; LaCasce, Ann Steward; Molina, Lysiane; Engley, Gerald; Fenton, Keenan; Jolin, Hina; L...
Journal:
Hematological oncology
Issue:
Volume 39:Issue 2(2021)
Page Start:
185
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial. Issue 6 (June 2021)

Authors:
Straus, David J; Długosz-Danecka, Monika; Connors, Joseph M; Alekseev, Sergey; Illés, Árpád; Picardi, Marco; Lech-Maranda, Ewa; Feldman, Tatyana; Smolewski, Piotr; Savage, Kerry J; Bartlett, Nancy L; Walewski, Jan; Ramchandren, Radhakrishnan; Zinzani, Pier Luigi; Hutchings, Martin; Munoz, Javier;...
Journal:
Lancet
Issue:
Volume 8:Issue 6(2021)
Page Start:
e410
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage III or IV classical Hodgkin lymphoma. (1st February 2019)

Authors:
Delea, Thomas E.; Sharma, Arati; Grossman, Aaron; Eichten, Caitlin; Fenton, Keenan; Josephson, Neil; Richhariya, Akshara; Moskowitz, Alison J.
Journal:
Journal of medical economics
Issue:
Volume 22:Number 2(2019)
Page Start:
117
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy. Issue 12 (14th October 2020)

Authors:
Straus, David; Collins, Graham; Walewski, Jan; Zinzani, Pier Luigi; Grigg, Andrew; Sureda, Anna; Illes, Arpad; Kim, Tae Min; Alekseev, Sergey; Specht, Lena; Buccheri, Valeria; Younes, Anas; Connors, Joseph; Forero-Torres, Andres; Fenton, Keenan; Gautam, Ashish; Purevjal, Indra; Liu, Rachael; Gall...
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 12(2020)
Page Start:
2931
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy. Issue 12 (14th October 2020)

Authors:
Straus, David; Collins, Graham; Walewski, Jan; Zinzani, Pier Luigi; Grigg, Andrew; Sureda, Anna; Illes, Arpad; Kim, Tae Min; Alekseev, Sergey; Specht, Lena; Buccheri, Valeria; Younes, Anas; Connors, Joseph; Forero-Torres, Andres; Fenton, Keenan; Gautam, Ashish; Purevjal, Indra; Liu, Rachael; Gall...
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 12(2020)
Page Start:
2931
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗